Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics
Glioblastoma multiforme is the most aggressive malignant tumor of the central nervous
system. Due to the absence of effective pharmacological and surgical treatments, the …
system. Due to the absence of effective pharmacological and surgical treatments, the …
Recent progress of targeted G-quadruplex-preferred ligands toward cancer therapy
A G-quadruplex (G4) is a well-known nucleic acid secondary structure comprising guanine-
rich sequences, and has profound implications for various pharmacological and biological …
rich sequences, and has profound implications for various pharmacological and biological …
Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes
The molecular foundations of Hürthle cell carcinoma (HCC) are poorly understood. Here we
describe a comprehensive genomic characterization of 56 primary HCC tumors that span …
describe a comprehensive genomic characterization of 56 primary HCC tumors that span …
Telomere length maintenance in cancer: at the crossroad between telomerase and alternative lengthening of telomeres (ALT)
Eukaryotic cells undergo continuous telomere shortening as a consequence of multiple
rounds of replications. During tumorigenesis, cells have to acquire telomere DNA …
rounds of replications. During tumorigenesis, cells have to acquire telomere DNA …
Mutant ATRX: uncovering a new therapeutic target for glioma
S Haase, MB Garcia-Fabiani, S Carney… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: ATRX is a chromatin remodeling protein whose main function is the deposition
of the histone variant H3. 3. ATRX mutations are widely distributed in glioma, and correlate …
of the histone variant H3. 3. ATRX mutations are widely distributed in glioma, and correlate …
[HTML][HTML] Telomere maintenance mechanisms in cancer
Tumour cells can adopt telomere maintenance mechanisms (TMMs) to avoid telomere
shortening, an inevitable process due to successive cell divisions. In most tumour cells …
shortening, an inevitable process due to successive cell divisions. In most tumour cells …
Integrated mutational landscape analysis of uterine leiomyosarcomas
Uterine leiomyosarcomas (uLMS) are aggressive tumors arising from the smooth muscle
layer of the uterus. We analyzed 83 uLMS sample genetics, including 56 from Yale and 27 …
layer of the uterus. We analyzed 83 uLMS sample genetics, including 56 from Yale and 27 …
Genomic footprints of activated telomere maintenance mechanisms in cancer
L Sieverling, C Hong, SD Koser, P Ginsbach… - Nature …, 2020 - nature.com
Cancers require telomere maintenance mechanisms for unlimited replicative potential. They
achieve this through TERT activation or alternative telomere lengthening associated with …
achieve this through TERT activation or alternative telomere lengthening associated with …
Infratentorial IDH-mutant astrocytoma is a distinct subtype
R Banan, D Stichel, A Bleck, B Hong, U Lehmann… - Acta …, 2020 - Springer
Diffuse IDH-mutant astrocytic tumors are rarely diagnosed in the cerebellum or brainstem. In
this multi-institutional study, we characterized a series of primary infratentorial IDH-mutant …
this multi-institutional study, we characterized a series of primary infratentorial IDH-mutant …
[HTML][HTML] Accelerating drug development for neuroblastoma: summary of the second neuroblastoma drug development strategy forum from innovative therapies for …
Only one class of targeted agents (anti-GD2 antibodies) has been incorporated into front-
line therapy for neuroblastoma since the 1980s. The Neuroblastoma New Drug …
line therapy for neuroblastoma since the 1980s. The Neuroblastoma New Drug …